Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
March 15, 2019
|
| |
| | | | | Findings from a nationwide analysis show racial disparities in asthma can largely be explained by examining socioeconomic and environmental factors including access to healthcare, reported from Emory news center. Click here to read more.
While the data reflect that African American patients visit the emergency department more frequently for asthma, these patients are less likely to see a doctor in an outpatient setting. This may be related to scheduling ... | | | | Read More | | |
|
| |
| | | | | Join Georgia Clinical & Translational Science Alliance colleagues at this 6th annual health services research symposium and networking opportunity. Oral and poster presentations will be selected from submitted abstracts. ... | | | | Read More | | |
|
| |
| | | | Georgia CTSA's Biostatistics, Epidemiology & Research Design (BERD) program is soliciting proposals to support novel methodological research in biostatistics, epidemiology, or health economics to advance clinical and translational research (CTR). Review criteria include: (i.) quantitative methodological research to fill gaps in CTR; (ii.) innovation; (iii.) feasibility; and (iv.) plans for dissemination and translation of results. Awardees are encouraged to disseminate any software developed in their research to CTSpedia, an online knowledge base for CTR, as well as other relevant publicly available software repositories. | | | | Read More | | |
| |
| | | | The SOM Imagine, Innovate and Impact (I3) Venture Awards solicit innovative research proposals to catalyze promising early-stage concepts with commercial potential that do not yet qualify for funding from external sources. The I3 Venture Research Awards aim to cultivate inventors, innovators, and entrepreneurs driven to solve medicine's challenges and create patient impact. In the current round, grants will be considered for: Proposals with the potential to shape, de-risk, or scale up a potential new drug or technology in medicine (diagnostic, therapeutic, device or software) in less than one year. If successful, the proposal would ready the project for the next stage of translation (not necessarily to market readiness). Particularly creative ideas, even without preliminary data, will be considered provided compelling impact, feasibility and commercial potential is demonstrated. Proposals due by 5:00pm on April 1st. | | | | Read More | | |
| |
| | | | This Funding Opportunity Announcement (FOA) invites applications for projects that propose to test late-stage (T4) implementation research strategies for optimally and sustainably delivering proven-effective, evidence-based multi--level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and that promote and improve population health in high-burden communities. For the purpose of this FOA, late-stage (T4) implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions in routine clinical and public health practice and community-based settings and maximize the positive impact on population health. | | | | Read More | | |
| |
| | | | The Purpose of this Funding Opportunity Announcement (FOA) is to provide support for Stage 3 of a multidisciplinary Dental, Oral and Craniofacial Tissue Regeneration Consortium (DOCTRC) that will facilitate advancement of promising strategies for regeneration and reconstruction of dental, oral and craniofacial (DOC) tissues to clinical trials. DOCTRC is composed of the Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) that have been built during Stage 2 of the DOCTRC effort. In Stage 3, the RCs will capitalize on their available clinical, scientific, industrial, regulatory and commercialization expertise, to deliver technical support, research capacity, administrative infrastructure and regulatory and commercialization support to the ITPs and guide them to complete pre-clinical studies toward initiation of clinical trials. During Stage 3, the DOCTRC will complete validation, manufacturing, and preclinical testing of the most promising tissue engineering and regenerative medicine (TE/RM) products and will develop Investigational New Drug/Device Exemption (IND/IDE) applications for submission to the Food and Drug Administration (FDA). The outcome of the DOCTRC will be TE/RM products with their IND/IDE in place and associated clinical study protocols, as well as synthesis and manufacturing protocols ready for initiation of clinical trials. | | | | Read More | | |
| |
| | | | The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support research on bioethical issues to develop an evidence base that may inform future policy directions. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. | | | | Read More | | |
| |
| | | | This Funding Opportunity Announcement (FOA) invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build comprehensive cancer health disparities research programs. It is the expectation that the research programs developed by the P20 awards should be competitive with other applications for a full Specialized Programs of Research Excellence (SPORE), addressing cancer health disparities as a cross-cutting research theme. | | | | Read More | | |
| |
| | | | This is the renewal of a Funding Opportunity Announcement (FOA), issued by NICHD, NINDS, NIBIB, NIDCD, NCCIH, and NINR, National Institutes of Health, to invite grant applications from institutions/organizations that propose to build a research infrastructure center to promote external collaboration with the medical rehabilitation community. The aim of this FOA is to create a national network of research centers that provide access to collateral expertise in biomedical, behavioral, engineering, and/or psychosocial fields that are particularly relevant to medical rehabilitation research and the needs of people with chronic physical disabilities. Specifically, the NIH is interested in addressing gaps in the rehabilitation research portfolio and is particularly interested in the following high-priority areas: pediatric rehabilitation; personalized medicine approaches; family, caregiver, and community support; implementation and dissemination research; clinical trial design; strategies to explore and validate combination therapies; and, technology to track real-world outcomes. | | | | Read More | | |
| |
| | | | Scholarship applications are being accepted for the Summer Institute in Statistical Genetics (SISG). All current graduate students are eligible to apply for tuition waivers for up to three modules. Please note postdocs are not eligible for SISG scholarships. Scholarship applications are due by March 31 (11:59 p.m. PST). Award notifications will be emailed by Friday, April 12. | | | | Read More | | |
| |
| | | | As of September 1, the new Pediatric Institute is in effect. As part of that transition, Children's Healthcare and Emory developed a revised IRB reliance agreement for collaborative research (research in which both Children's and Emory are engaged). | | | | Read More | | |
| |
| | | | The Research Registry Toolkit is designed to support teams creating and managing research registries. Each section includes examples, best practices, and tools to guide conversations about research registry development and maintenance. | | | | Read More | | |
| |
| | | | The statistics research group directed by ISyE associate professor Yajun Mei, is now offering free consulting for data-analysis questions in the domain of bio-related initiatives on the GA Tech Campus, every Monday from 10:30am to 11:30am in Room 3317 of the Petit Building during the 2018 fall and 2019 spring semester, starting from Monday, October 1, 2018. | | | | Read More | | |
| |
| | | | A free weekly walk-in statistical consulting clinic for Morehouse School of Medicine faculty, staff, and students from 10:00 a.m.-noon in MRC Annex, Bldg. F, S-14 Conference Room. | | | | Read More | | |
| |
| | | | The NCATS ASPIRE Design Challenges are designed to advance innovative and catalytic approaches towards solving the opioid crisis by developing. A Specialized Platform for Innovative Research Exploration (ASPIRE) to aid in the discovery and development of novel and effective treatments, while at the same time making the process faster and more cost-effective. The NCATS ASPIRE Design Challenges are part of the of the NIH's Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. Solutions must be submitted to Challenge.gov by NOON Eastern Time on May 31, 2019. | | | | Read More | | |
| |
| |  | | Georgia CTSA Community Engagement program’s 4th biennial forum held at Atlanta Technical College, Dennard Conference Center on April 25-26. Abstract submission is open to all professionals, students, and community members who have interest or who are working in fields that include, but are not limited to:
allied health professionals, academic researchers, basic scientists, behavioral scientists, clinicians, community-based organizations, faith-based ... | | | | Read More | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | David M. Guidot (Professor, DOM Pulmonary) will present a seminar sponsored by HERCULES and the graduate program in Nutrition and Health Sciences entitled: "Dietary Supplements as a Therapeutic Approach to HIV- and Alcohol-Mediated Lung Disease " on Monday, March 18th at 12pm in the School of Medicine Building, Room 170A. Snacks and coffee provided. | | | | Read More | | |
| |
| | | | Learn how to move from specific aims to go/no-go commercial milestones. This interactive workshop will guide you through the process of determining your most killer experiment. Choose between Workshop Option 1 on Tuesday, March 19 from 11:00 a.m. -12:30 p.m. at Georgia Tech or Workshop Option 2, Wednesday, March 20 at 8:00 a.m.-9:30 a.m. at Emory School of Medicine. | | | | Read More | | |
| |
| | | | In honor of Women's History Month, Join Women In Bio and our partner: Georgia Innovation Crescent, an organization dedicated to supporting growth in Georgia's life science and technology sector, to hear women in leadership roles discuss their journeys! Discussion topics will include challenges faced and strategies to overcome them, mentorship, and how they have navigated the leadership structure in their careers. Refreshments will be provided. Wednesday, March 27 from 6:00 p.m. -9:00 p.m. at Arbor Pharmaceuticals. | | | | Read More | | |
| |
| | | | Description: Register to attend the 2nd Annual Drs. Peter and Marlene MacLeish Endowed Lectureship lectures Wednesday March 27-Thursday March 28, 2019. This year's lecturer is Dr. Emery Brown, Ph.D., M.D., the Edward Hood Taplin Professor of Medical Engineering and Computational Neuroscience at Massachusetts Institute of Technology (MIT), the Warren M. Zapol Professor of Anesthesia at Harvard Medical School and a practicing anesthesiologist at Massachusetts General Hospital. Dr. Brown's presentation is titled, "Deciphering the Dynamics of the Unconscious Brain Under General Anesthesia." The Drs. Peter and Marlene MacLeish Endowed Lectureship Series is a Morehouse School of Medicine (MSM) event established to: recognize and celebrate the contribution of basic science, to invigorate and inspire students and junior faculty, and inform the general public about advances in biomedical science and its impact on health. | | | | Read More | | |
| |
| | | | Join the University of Wyoming School of Pharmacy and the Wyoming Small Business Development Center Network at 12:00 p.m. to learn about the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health, and the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS offers non-dilutive funding and resources to support technology transfer offices and to help small businesses advance and commercialize promising translational biomedical and health care research technologies. If you are a biomedical or clinical researcher interested in bringing your innovations to market, consider applying for the NCATS SBIR and STTR programs. | | | | Read More | | |
| |
| | | | Review historical & epidemiologic findings related to racial/ethnic disparities in health & health care in the US. Discuss how implicit bias, stereotyping, & the "isms" can impact the clinical encounter & related challenges in undertaking disparities research. Share helpful resources for engaging & partnering with communities involved in health equity research. Examine two case studies as a group. | | | | Read More | | |
| |
| | | | The SEMDA Medtech Conference is the premier medical technology forum fostering business and educational opportunities for the medtech industry, including medical devices, diagnostics, and digital health.After a record-breaking 2018, SEMDA IS BACK as the must attend event for industry wishing to do business in the southeast region. Join attendees from across the country for the premier medical technology forum in the southeast. | | | | Read More | | |
| |
| |  | | Join Georgia Clinical & Translational Science Alliance colleagues at this 6th annual health services research symposium and networking opportunity. Oral and poster presentations will be selected from submitted abstracts. ... | | | | Read More | | |
| |
| | | | | | Hosted by Emory University School of Medicine, this symposium will provide a forum where the newest developments in basic, translational and clinical immunology will be shared with the goal of fostering increased relationships and collaborations. Several leading faculty from institutions across the southeast will present their work. Additionally, distinguished keynote speakers will present their most recent advances. Registration, hotel registration and abstract submission deadline May 3. | | | | Read More | | |
|
| |
| | | | Hosted by the Pediatric Research Alliance institutions of Emory University, Children's Healthcare of Atlanta, Georgia Tech and Morehouse School of Medicine. Limited number of travel awards for oral and poster presenters coming from more than 100 miles outside of metro Atlanta, based on merit and need. $40 registration fee is waived for students, residents, postdocs and fellows. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
